Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,153,545
+$114,667 QoQ
Shares Held
12,417
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#1,974
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Dimensions Group, Ltd. holds $13,797,187 across 9 Drug Manufacturers - General names. JNJ ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,627 | $4,350,332 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,417 | $3,153,545 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,763 | $2,025,545 | |
| 4 | ABBV |
AbbVie Inc.
|
5,070 | $1,275,814 | |
| 5 | AMGN |
Amgen Inc
|
3,220 | $1,166,026 | |
| 6 | PFE |
Pfizer Inc
|
25,257 | $608,188 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,551 | $492,708 | |
| 8 | AZN |
Astrazeneca PLC
|
2,002 | $379,619 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,153,545 | 12,417 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $3,038,878 | 12,432 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,655,789 | 12,833 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,447,914 | 13,202 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,062,277 | 13,501 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,259,072 | 13,622 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,954,539 | 13,515 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,252,471 | 13,899 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,032,500 | 13,906 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,369,053 | 14,976 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,390,441 | 15,251 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,388,582 | 15,336 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,584,263 | 15,613 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,473,025 | 15,955 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,067,350 | 17,364 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,692,336 | 16,481 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,913,294 | 16,412 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,894,343 | 16,331 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,729,079 | 15,953 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,544,594 | 15,756 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,362,865 | 14,343 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,281,671 | 13,883 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,172,001 | 13,801 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||